A detailed history of Annex Advisory Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Annex Advisory Services, LLC holds 6,412 shares of BMY stock, worth $370,357. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,412
Previous 6,296 1.84%
Holding current value
$370,357
Previous $261,000 26.82%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$39.66 - $51.75 $4,600 - $6,003
116 Added 1.84%
6,412 $331,000
Q2 2024

Jul 12, 2024

SELL
$40.25 - $52.99 $24,552 - $32,323
-610 Reduced 8.83%
6,296 $261,000
Q1 2024

Apr 12, 2024

SELL
$47.98 - $54.4 $167,594 - $190,019
-3,493 Reduced 33.59%
6,906 $374,000
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $5.08 Million - $6.06 Million
-104,838 Reduced 90.98%
10,399 $533,000
Q3 2023

Oct 31, 2023

BUY
$57.89 - $64.73 $29,523 - $33,012
510 Added 0.44%
115,237 $6.69 Million
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $96,584 - $107,241
-1,516 Reduced 1.3%
114,727 $7.34 Million
Q1 2023

Apr 27, 2023

BUY
$65.71 - $74.53 $2.51 Million - $2.84 Million
38,158 Added 48.87%
116,243 $8.06 Million
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $79,779 - $94,469
1,165 Added 1.51%
78,085 $5.62 Million
Q3 2022

Oct 24, 2022

SELL
$0.13 - $76.84 $316 - $186,874
-2,432 Reduced 3.06%
76,920 $5.47 Million
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $22,076 - $24,313
-304 Reduced 0.38%
79,352 $6.11 Million
Q1 2022

Apr 13, 2022

BUY
$61.48 - $73.72 $274,692 - $329,380
4,468 Added 5.94%
79,656 $5.82 Million
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $402,654 - $469,400
7,508 Added 11.09%
75,188 $4.69 Million
Q3 2021

Oct 18, 2021

BUY
$59.17 - $69.31 $266,501 - $312,172
4,504 Added 7.13%
67,680 $4 Million
Q2 2021

Jul 29, 2021

BUY
$61.91 - $67.42 $218,666 - $238,127
3,532 Added 5.92%
63,176 $4.22 Million
Q1 2021

Apr 22, 2021

BUY
$59.34 - $66.74 $320,851 - $360,863
5,407 Added 9.97%
59,644 $3.77 Million
Q4 2020

Jan 28, 2021

BUY
$57.74 - $65.43 $273,225 - $309,614
4,732 Added 9.56%
54,237 $3.36 Million
Q3 2020

Oct 23, 2020

SELL
$57.43 - $63.64 $5,455 - $6,045
-95 Reduced 0.19%
49,505 $2.99 Million
Q2 2020

Jul 21, 2020

BUY
$54.82 - $64.09 $219,444 - $256,552
4,003 Added 8.78%
49,600 $2.92 Million
Q1 2020

Apr 22, 2020

BUY
$46.4 - $67.43 $263,737 - $383,272
5,684 Added 14.24%
45,597 $2.54 Million
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $16 Million - $20.8 Million
-324,330 Reduced 89.04%
39,913 $2.56 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $16.6 Million - $21.6 Million
337,230 Added 1248.4%
364,243 $7.37 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $1.16 Million - $1.37 Million
27,013 New
27,013 $1.37 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Annex Advisory Services, LLC Portfolio

Follow Annex Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annex Advisory Services, LLC with notifications on news.